M. Kopitar

540 total citations
24 papers, 387 citations indexed

About

M. Kopitar is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, M. Kopitar has authored 24 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in M. Kopitar's work include Protease and Inhibitor Mechanisms (12 papers), Peptidase Inhibition and Analysis (7 papers) and Protein Hydrolysis and Bioactive Peptides (7 papers). M. Kopitar is often cited by papers focused on Protease and Inhibitor Mechanisms (12 papers), Peptidase Inhibition and Analysis (7 papers) and Protein Hydrolysis and Bioactive Peptides (7 papers). M. Kopitar collaborates with scholars based in Slovenia, Italy and United States. M. Kopitar's co-authors include Vito Türk, Anka Ritonja, Roman Jerala, Jože Brzin, Igor Križaj, J. Babnik, Neville Marks, Frederic Stern, Blaž Rozman and Tze-Chein Wun and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Thrombosis and Haemostasis.

In The Last Decade

M. Kopitar

24 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Kopitar Slovenia 8 212 130 104 76 48 24 387
Peter W. M. Reisinger Germany 10 199 0.9× 38 0.3× 36 0.3× 60 0.8× 27 0.6× 18 362
Mara Fortunato United Kingdom 10 313 1.5× 41 0.3× 181 1.7× 91 1.2× 46 1.0× 11 555
Virginie Hervé‐Grépinet France 8 131 0.6× 74 0.6× 69 0.7× 49 0.6× 15 0.3× 9 302
Tulene S. Kendrick Australia 7 395 1.9× 28 0.2× 130 1.3× 60 0.8× 20 0.4× 11 590
Markus Walz Germany 15 354 1.7× 59 0.5× 34 0.3× 184 2.4× 18 0.4× 21 574
Peter J. Tatnell United Kingdom 11 192 0.9× 20 0.2× 64 0.6× 85 1.1× 28 0.6× 20 356
Adri Van Vliet Belgium 8 622 2.9× 46 0.4× 37 0.4× 263 3.5× 67 1.4× 8 897
Qingdi Q. Li United States 12 274 1.3× 32 0.2× 66 0.6× 55 0.7× 17 0.4× 15 475
Steven Szarka Canada 8 356 1.7× 17 0.1× 44 0.4× 36 0.5× 239 5.0× 8 509
Kathrin Thell Austria 7 313 1.5× 39 0.3× 32 0.3× 158 2.1× 41 0.9× 12 442

Countries citing papers authored by M. Kopitar

Since Specialization
Citations

This map shows the geographic impact of M. Kopitar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kopitar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kopitar more than expected).

Fields of papers citing papers by M. Kopitar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Kopitar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kopitar. The network helps show where M. Kopitar may publish in the future.

Co-authorship network of co-authors of M. Kopitar

This figure shows the co-authorship network connecting the top 25 collaborators of M. Kopitar. A scholar is included among the top collaborators of M. Kopitar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Kopitar. M. Kopitar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jerala, Roman, et al.. (1991). Deletion of the carboxy terminal part of stefin B does not have a major effect for binding to papain.. PubMed. 50(4-6). 627–9. 1 indexed citations
2.
Ritonja, Anka, Igor Križaj, M. Kopitar, et al.. (1990). The amino acid sequence of a novel inhibitor of cathepsin D from potato. FEBS Letters. 267(1). 13–15. 55 indexed citations
3.
Drobnič‐Košorok, M., M. Kopitar, J. Babnik, Roman Jerala, & Vito Türk. (1990). A New Inhibitor of Plasmin and Trypsin from Porcine Leukocytes. Biological Chemistry Hoppe-Seyler. 371(1). 57–62. 2 indexed citations
4.
Ritonja, Anka, M. Kopitar, Roman Jerala, & Vito Türk. (1989). Primary structure of a new cysteine proteinase inhibitor from pig leucocytes. FEBS Letters. 255(2). 211–214. 126 indexed citations
5.
Kopitar, M., et al.. (1989). A New Type of Low-Molecular Mass Cysteine Proteinase Inhibitor from Pig Leukocytes. Biological Chemistry Hoppe-Seyler. 370(2). 1145–1152. 34 indexed citations
6.
Kopitar, M., et al.. (1985). Human Leucocyte Urokinase Inhibitor - Purification, Characterization and Comparative Studies Against Different Plasminogen Activators. Thrombosis and Haemostasis. 54(4). 750–755. 40 indexed citations
7.
Pavelić, Krešimir, et al.. (1983). Murine myeloid leukemia: in vivo suppression by sericystatin A, a proteinase inhibitor from leukocytes. European Journal of Cancer and Clinical Oncology. 19(1). 123–126. 1 indexed citations
8.
Kopitar, M., Frederic Stern, & Neville Marks. (1983). Cerebrocystatin suppresses degradation of myelin basic protein by purified brain cysteine proteinase. Biochemical and Biophysical Research Communications. 112(3). 1000–1006. 23 indexed citations
9.
Kopitar, M., Jože Brzin, M. Drobnič‐Košorok, et al.. (1982). Some further characteristics of endogenous proteinase inhibitors.. PubMed. 41(1). 75–82. 3 indexed citations
10.
Kopitar, M., et al.. (1982). The isolation of liver serine proteinase by affinity chromatography on 4-phenylbutylamine-sepharose 4 B.. PubMed. 41(1). 61–8. 2 indexed citations
11.
Brzin, Jože, et al.. (1982). An endogenous inhibitor of cysteine and serine proteinases from spleen. FEBS Letters. 138(2). 193–197. 13 indexed citations
12.
Kopitar, M., et al.. (1981). Inhibitory mechanism of sericystatin, an intracellular proteinase inhibitor, reacting with cysteine proteinases.. PubMed. 362(10). 1411–4. 3 indexed citations
13.
Giraldi, Tullio, Gianni Sava, M. Kopitar, Jože Brzin, & Vito Türk. (1980). Neutral proteinase inhibitors and antimetastatic effects in mice. European Journal of Cancer (1965). 16(4). 449–454. 17 indexed citations
14.
Babnik, J., M. Kopitar, & Vito Türk. (1980). Immunological Studies of Intracellular Leukocyte Proteinase Inhibitor by Granular Extract and Cathepsin D. Advances in experimental medicine and biology. 85–90. 2 indexed citations
15.
Kopitar, M., et al.. (1980). Biochemical and Biological Properties of Leukocyte Intracellular Inhibitors of Proteinases. Advances in experimental medicine and biology. 121(A). 75–83. 5 indexed citations
16.
Kopitar, M., et al.. (1977). Biochemical and biological properties of cell and tissue neutral proteinases and inhibitors. PubMed. 36(11-12). 1863–1872. 2 indexed citations
17.
Brzin, Jože, M. Kopitar, & Vito Türk. (1977). Isolation and characterization of inhibitors of neutral proteinases from spleen. PubMed. 36(11-12). 1883–1886. 2 indexed citations
18.
Kopitar, M., I. Kregar, & D. Lebez. (1971). Leucocyte proteinases. II. Partial purification of proteinases present in cathepsin D preparation.. PubMed. 41(2). 129–39. 3 indexed citations
19.
Lebez, D. & M. Kopitar. (1970). Leucocyte proteinases. I. Low molecular weight cathepsins of F and G type.. PubMed. 39(5). 271–83. 6 indexed citations
20.
Kopitar, M., et al.. (1966). Effect of local irradiation on the proteolytic activity of leucocytes in cancer patients.. PubMed. 129(4). 596–603. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter W. M. Reisinger Breakdown of academic impact, for papers by Mara Fortunato Breakdown of academic impact, for papers by Virginie Hervé‐Grépinet Breakdown of academic impact, for papers by Tulene S. Kendrick Breakdown of academic impact, for papers by Markus Walz Breakdown of academic impact, for papers by Peter J. Tatnell Breakdown of academic impact, for papers by Adri Van Vliet Breakdown of academic impact, for papers by Qingdi Q. Li Breakdown of academic impact, for papers by Steven Szarka Breakdown of academic impact, for papers by Kathrin Thell
Rankless by CCL
2026